The Cooper Companies (COO) Stock
NASDAQ · COO
55.29
Fundamentals
Market cap
$10.51B
Price / Earnings ratio
17.9x
Price / Sales ratio
2.4x
Price / Book ratio
1.2x
Return on assets
0.0%
Ex-Dividend date
26 Jul 2023
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About The Cooper Companies
CooperCompanies is a global medical device company, operating through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees15,000
CEOMr. Albert G. White III
IPO DateDec 30, 1983
HeadquartersSan Ramon, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Albert G. White III | President, CEO & Non-Independent Director | 1970 |
| Mr. Daniel G. McBride Esq. | Executive VP, COO General Counsel & Secretary | 1964 |
| Ms. Holly R. Sheffield | President of CooperSurgical, Inc. | 1971 |
| Mr. Gerard H. Warner III | President of CooperVision, Inc. | 1965 |
| Mr. Kim Duncan | Vice President of Investor Relations & Risk Management | — |
Fundamentals
Valuation
Market cap$10.51B
Price-to-sales ratio2.41
Price-to-book value1.23
Price-earnings ratio17.90
Return on Equity3.00%
Return on Sales0.12%
Return on Assets0.02%
PEG ratio0.72
Earnings Per Share
Earnings Per Share$2.94
Income Statement
Average volume3,643,957
EBITDA$935.90M
1 year high (52w)$89.83
1 year low (52w)$51.01
Dividend
Ex dividend date26 Jul 2023
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



